Free Trial

Legend Biotech (LEGN) News Today

Legend Biotech logo
$29.32 +0.37 (+1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$29.48 +0.16 (+0.53%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LEGN Latest News

Legend Biotech Co. stock logo
Lansforsakringar Fondforvaltning AB publ Takes Position in Legend Biotech Co. (NASDAQ:LEGN)
Lansforsakringar Fondforvaltning AB publ purchased a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 28,093 shares of the
Legend Biotech Co. stock logo
Wellington Management Group LLP Buys 84,405 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Wellington Management Group LLP boosted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,120,775 shares of the company
Legend Biotech Co. stock logo
Polar Asset Management Partners Inc. Increases Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Polar Asset Management Partners Inc. grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 65.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,638 shares of the company's stock after buying
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company's stock after acquiring an additional 39,197
Legend Biotech Co. stock logo
Woodline Partners LP Boosts Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Woodline Partners LP raised its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 10.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 120,304 shares of the company's stock after purchasing an additional 10,909 shares dur
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Millennium Management LLC
Millennium Management LLC reduced its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 55.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 255,468 shares of the company's st
Legend Biotech Co. stock logo
Two Sigma Advisers LP Raises Position in Legend Biotech Co. (NASDAQ:LEGN)
Two Sigma Advisers LP boosted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 904.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 327,400 shares of the company's stock after buying an additional 294,800
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Stock Position Lifted by Twinbeech Capital LP
Twinbeech Capital LP grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 132.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 73,168 shares of the company's stock after purchasing an additional 41,710 shares during
Legend Biotech Co. stock logo
Two Sigma Investments LP Acquires 581,952 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Two Sigma Investments LP increased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 961.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 642,452 shares of the company's stock after purchasing an additional 581,952 sha
Legend Biotech Co. stock logo
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Still a Buy?
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's What Happened
Legend Biotech Co. stock logo
Deutsche Bank AG Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)
Deutsche Bank AG increased its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 11.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,067 shares of the c
Legend Biotech Co. stock logo
Vestal Point Capital LP Has $15.46 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)
Vestal Point Capital LP increased its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 280.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 475,000 shares of the company's stock af
Legend Biotech Co. stock logo
Tema Etfs LLC Makes New $370,000 Investment in Legend Biotech Co. (NASDAQ:LEGN)
Tema Etfs LLC purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 11,362 shares of the company's
Legend Biotech Co. stock logo
Bank of America Corp DE Buys 467,386 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Bank of America Corp DE grew its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 192.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 710,626 shares of the company's stock after ac
Legend Biotech Co. stock logo
Tiger Pacific Capital LP Buys 53,100 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Tiger Pacific Capital LP grew its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 31.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 222,000 shares of the company's stock after a
Legend Biotech Co. stock logo
Tang Capital Management LLC Makes New $14.64 Million Investment in Legend Biotech Co. (NASDAQ:LEGN)
Tang Capital Management LLC acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 450,000 shares of the company's sto
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Position Increased by Polar Asset Management Partners Inc.
Polar Asset Management Partners Inc. grew its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 65.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 24,638 shares of the company's stock after purchasing an additional 9,779
Legend Biotech Co. stock logo
Northern Trust Corp Has $9.26 Million Position in Legend Biotech Co. (NASDAQ:LEGN)
Northern Trust Corp grew its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 239.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 284,678 shares of the company's stock after buying an additional 200,
Legend Biotech Co. stock logo
Q2 EPS Estimates for Legend Biotech Lifted by HC Wainwright
Legend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at HC Wainwright boosted their Q2 2025 earnings estimates for Legend Biotech in a research note issued on Wednesday, May 14th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings per share of $0.3
Legend Biotech Co. stock logo
Suvretta Capital Management LLC Invests $113.77 Million in Legend Biotech Co. (NASDAQ:LEGN)
Suvretta Capital Management LLC purchased a new stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,496,234 shares of the company's stock,
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Polar Capital Holdings Plc
Polar Capital Holdings Plc trimmed its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 23.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 381,873 shares of the company's stock after selling 11
Legend Biotech Co. stock logo
Ameriprise Financial Inc. Has $24.94 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Ameriprise Financial Inc. raised its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 766,440 shares of the company's stock af
Legend Biotech Co. stock logo
Legend Biotech (NASDAQ:LEGN) Hits New 52-Week Low on Analyst Downgrade
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst Downgrade
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by LMR Partners LLP
LMR Partners LLP decreased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 46.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,200 shares of the company's stock after selling 57,20
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Receives Average Recommendation of "Moderate Buy" from Analysts
Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating o
Legend Biotech Co. stock logo
Janus Henderson Group PLC Has $70.20 Million Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Janus Henderson Group PLC trimmed its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,156,749 shares of the company's stoc
Legend Biotech Co. stock logo
Hudson Bay Capital Management LP Invests $6.59 Million in Legend Biotech Co. (NASDAQ:LEGN)
Hudson Bay Capital Management LP bought a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 202,500 shares of the company's stock, valued at app
Legend Biotech Co. stock logo
BNP Paribas Financial Markets Invests $7.94 Million in Legend Biotech Co. (NASDAQ:LEGN)
BNP Paribas Financial Markets acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 243,989 shares of the company's stock, v
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Bought by Stifel Financial Corp
Stifel Financial Corp increased its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 70.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 31,365 shares of the company's stock after acquirin
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Purchased by First Trust Advisors LP
First Trust Advisors LP increased its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 76.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 20,669 shares of the company's stock after acquiring an
Legend Biotech Co. stock logo
Deerfield Management Company L.P. Series C Invests $50.49 Million in Legend Biotech Co. (NASDAQ:LEGN)
Deerfield Management Company L.P. Series C acquired a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,551,718 shares of the company's stock, valued at
Legend Biotech Co. stock logo
Legend Biotech (LEGN) to Release Earnings on Tuesday
Legend Biotech (NASDAQ:LEGN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-legend-biotech-co-stock/)
Legend Biotech Co. stock logo
Braidwell LP Acquires 1,436,400 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Braidwell LP lifted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 93.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,977,951 shares of the company's stock after buying an additional 1,436,400 shares during the period.
Legend Biotech Co. stock logo
Alyeska Investment Group L.P. Acquires Shares of 250,000 Legend Biotech Co. (NASDAQ:LEGN)
Alyeska Investment Group L.P. acquired a new position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 250,000 shares of the company's stock,
Legend Biotech Co. stock logo
ArrowMark Colorado Holdings LLC Acquires 223,975 Shares of Legend Biotech Co. (NASDAQ:LEGN)
ArrowMark Colorado Holdings LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 23.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,177,540 shares of the company's stock after buying an additional 223,975 shares during t
Legend Biotech Co. stock logo
Boxer Capital Management LLC Buys New Shares in Legend Biotech Co. (NASDAQ:LEGN)
Boxer Capital Management LLC bought a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 700,000 shares of the company's stock, valued at approxima
The Play On Legend Biotech
Legend Biotech Co. stock logo
Hhlr Advisors LTD. Has $194.74 Million Stock Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Hhlr Advisors LTD. trimmed its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 9.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,984,550 shares of the company's stock after selling 6
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Purchased by Tri Locum Partners LP
Tri Locum Partners LP raised its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 388,704 shares of the company's stock after buying an additional 26,434 shares during
Legend Biotech Co. stock logo
Barclays PLC Sells 33,779 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Barclays PLC cut its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 21.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 126,571 shares of the company's stock after selling 33,779
Legend Biotech Co. stock logo
Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Decheng Capital LLC
Decheng Capital LLC increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 41.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 153,558 shares of
Get Legend Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.

LEGN Media Mentions By Week

LEGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LEGN
News Sentiment

1.25

0.90

Average
Medical
News Sentiment

LEGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LEGN Articles
This Week

7

6

LEGN Articles
Average Week

Get Legend Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LEGN) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners